including the pretransplant identification of those at risk from pulmonary complications and the use of cytokines to speed engraftment, have reduced morbidity and mortality to such a degree that it is appropriate to consider high-dose therapy and stem cell reconstitution in patients with nonmalignant ...
... 全血细胞计数 complete blood count 脐带血干细胞移植 cord blood stem cell transplantatio…www.lcjyzz.com|基于2个网页 更多释义 例句 释义: 全部,脐血干细胞移植,脐带血移植,脐带血干细胞移植 更多例句筛选 1. Unrelated umbilical cord blood stem cell transplantation in a patient with chronic ...
including the pretransplant identification of those at risk from pulmonary complications and the use of cytokines to speed engraftment, have reduced morbidity and mortality to such a degree that it is appropriate to consider high-dose therapy and stem cell reconstitution in patients with nonmalignant ...
血液干细胞的移植 (Peripheral blood stem cell transplants)-移植干细胞的优点在於不需要麻醉,而且血液的复元会很快类固醇 …m.cancer-fund.org|基于16个网页 2. 周边血液干细胞的移植 淋巴癌的预防及治疗方法... ... 周边血液干细胞的移植( Peripheral blood stem cell transplants) 类固醇治疗( Steroid therap...
7. Song Y, Zhao HY, Lyu ZS, et al. Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.2018;24(10):1981...
These findings have enabled the researchers to understand why stem cell transplants are usually so successful. But lamentably, says Martin, the treatment is not approved in many countries, as phase III studies are lacking. "Phase III studies cost several hundred million euros, and pharmaceutical ...
Stem cell collection Sources of stem cells used for autotransplants and allotransplants include peripheral blood, bone marrow, and umbilical cord blood.1 For this reason, the term, bone marrow transplantation, has been replaced by HSCT, because bone marrow is no longer used as the sole source...
MCRI Professor Andrew Elefanty said while a blood stem cell transplant was often a key part of lifesaving treatment for childhood blood disorders, not all children found an ideally matched donor. "Mismatched donor immune cells from the transplant can attack the recipient's own tissues, leading to...
An antibody-based conditioning agent may open the way to wider application of gene therapy with hematopoietic stem cells.doi:10.1038/nbt.3629AlessandroAiutiLuigiNaldiniNature biotechnologyAiuti, A., and Naldini, L. (2016). Safer conditioning for blood stem cell transplants. Nat. Biotechnol. 34, ...
Bone marrow and peripheral blood stem cell transplants are ways to treat blood cancers like leukemia, multiple myeloma, and non-Hodgkin's lymphoma. They help restore the body’s ability to make blood cells after high-dose chemotherapy or radiation. As many as 50,000 new transplants are done...